Atorvastatin-preconditioned HUMSC attenuate atherosclerosis via exosomes transfer of hsa-miR-454-3p targeting IRF1/NF-kB to modulate macrophage polarization
29 August 2025 (07:00 - 18:00)
Organised by: 

About the speaker

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
6 More presentations in this session
Associate Professor S. Bollini (Genova, IT)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
